phenelzine has been researched along with Panic Attacks in 9 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phenelzine (PLZ), a nonselective monoamine oxidase inhibitor, is widely used in psychiatry for the treatment of panic disorder and depression." | 3.68 | Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function. ( Baker, GB; Coutts, RT; Greenshaw, AJ; McKenna, KF, 1992) |
| "Because the other standard treatments of panic disorder, the SSRIs, have a slow onset of action, adding an extended-release benzodiazepine to the treatment regimen for the initial 6 to 8 weeks could serve as an effective bridge until the desired SSRI effect is realized." | 2.41 | The management of panic disorder. ( Sheehan, DV, 2002) |
| " There was no correlation of pyridoxal phosphate level with phenelzine daily dosage over the range of 30 mg to 90 mg." | 1.29 | Phenelzine reduces plasma vitamin B6. ( Bowen, RC; Hawkes, J; Hussein, M; Malcolm, DE; O'Donovan, C; Yu, PH, 1994) |
| "Posttraumatic stress disorder (PTSD) is frequently associated with major depressive disorder, and antidepressants have been reported to ameliorate PTSD symptoms in some patients." | 1.29 | Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment. ( Abramovitz-Schnaider, P; Freudstein-Dan, A; Laor, N; Rehavi, M; Schujovitsky, A; Weizman, R; Wolmer, L, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheehan, DV | 1 |
| Buch, S | 1 |
| Wagner, M | 1 |
| Dassylva, B | 1 |
| Fontaine, R | 1 |
| Malcolm, DE | 1 |
| Yu, PH | 1 |
| Bowen, RC | 1 |
| O'Donovan, C | 1 |
| Hawkes, J | 1 |
| Hussein, M | 1 |
| Weizman, R | 1 |
| Laor, N | 1 |
| Schujovitsky, A | 1 |
| Wolmer, L | 1 |
| Abramovitz-Schnaider, P | 1 |
| Freudstein-Dan, A | 1 |
| Rehavi, M | 1 |
| Tanay, VA | 1 |
| Glencorse, TA | 1 |
| Greenshaw, AJ | 2 |
| Baker, GB | 2 |
| Bateson, AN | 1 |
| Gracious, BL | 1 |
| Wisner, KL | 1 |
| Griebel, G | 1 |
| Curet, O | 1 |
| Perrault, G | 1 |
| Sanger, DJ | 1 |
| McKenna, KF | 1 |
| Coutts, RT | 1 |
3 reviews available for phenelzine and Panic Attacks
| Article | Year |
|---|---|
The management of panic disorder.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Delayed-Act | 2002 |
[Atypical depression: evolution toward a specific pharmacologic and efficacious treatment?].
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Controlled Clinical Trials as Topic; Depres | 1995 |
Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommendations.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Monoa | 1997 |
6 other studies available for phenelzine and Panic Attacks
| Article | Year |
|---|---|
Successful use of phenelzine in treatment-resistant panic disorder.
Topics: Drug Resistance; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Panic Disorder; Phenelzine | 2007 |
Phenelzine reduces plasma vitamin B6.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Female; Humans; Male; Middle Aged; Panic Disorder; Phe | 1994 |
Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment.
Topics: Adult; Agoraphobia; Anxiety Disorders; Binding Sites; Blood Platelets; Depressive Disorder; Humans; | 1996 |
Chronic administration of antipanic drugs alters rat brainstem GABAA receptor subunit mRNA levels.
Topics: Animals; Anti-Anxiety Agents; Brain Stem; Buspirone; GABA Agonists; GABA-A Receptor Agonists; Imipra | 1996 |
Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Biogenic Monoamines; Bites and Stings; | 1998 |
Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Biogenic Amines; Body Weight; Brain; | 1992 |